Back to top

Alcohol Use Disorder: Diagnosing a Troubling Trend

Share this on:
Let's Talk - A Professional Development Webinar Series

With record-level alcohol sales and consumption reported during the COVID-19 pandemic, the rise in alcohol-related emergency room visits shouldn’t come as a surprise. A marked increase in alcohol-related deaths is another tragic trend. Where is the line between heavy or risky alcohol use and an alcohol use disorder? Which screening, assessment and diagnostic tools are most effective? Join Hazelden Betty Ford medical director Stephen Delisi, MD, to take a closer look at troubling alcohol-use trends, diagnostic criteria and treatment options. Using a case-based approach, Dr. Delisi will discuss the risk factors, symptoms, diagnosis and treatment of alcohol use disorders.

- Describe the effects of the COVID-19 pandemic on alcohol consumption
- Recognize the prevalence of alcohol use disorder
- Identify known risk factors for developing an alcohol use disorder
- Define key terms related to at-risk use, binge drinking and alcohol use disorder
- Discuss screening, assessment, diagnosis and treatment of alcohol use disorder, including FDA-approved medication

Can't attend on the scheduled date?
Register and you'll receive notice when we post the recording for on-demand viewing.

A certificate of completion will be awarded for attending this event. Please note, this event has not been approved for continuing education (CE) credit. The participant is responsible to verify if this activity meets their continuing education board requirements in order to gain credit.

Steve Delisi

A clinical psychiatrist, Stephen Delisi, MD, serves as medical director of professional education solutions for the Hazelden Betty Ford Foundation and an associate professor at the Hazelden Betty Ford Graduate School of Addiction Studies. Dr. Delisi is board certified by both the American Board of Psychiatry and Neurology and the American Board of Addiction Medicine. He is a nationally recognized expert on the implementation of integrated, evidence-based treatments for substance use disorders and co-occurring mental health disorders, and has co-authored numerous abstracts and presentations on the topic. Dr. Delisi joined the Hazelden Betty Ford Foundation in 2005, and has served in key leadership positions including Midwest regional medical director and assistant dean of the graduate school. Prior to joining the Hazelden Betty Ford Foundation, Dr. Delisi was the director of psychiatric services at Rush Behavioral Health-DuPage and associate director of Rush University Medical Center’s psychiatric residency program.

RSVP Required
Date & Time: 
Wednesday, August 11, 2021 1:30 pm

15245 Pleasant Valley Rd, Center City, MN 55012